all report title image
  • Published On : Aug 2021
  • Code : CMI4569
  • Industry : Pharmaceutical
  • Pages : 465
  • Formats :

The pharmaceutical industry is responsible for the research, development, production, and distribution of medications. The pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition, and patent cliffs. Innovation is of vital importance for steady growth of key market players. They have been mainly dependent on a few blockbuster molecules. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex. This is influencing players offering complementary products and services to collaborate for new product development. Moreover, key market players are investing in consumer health products, with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging the key market players to enter the OTC market and leverage their brand equity among the doctors, chemists, and consumers.

Market Dynamics

The increasing prevalence of chronic diseases such as diabetes, cancer, cardiovascular disease, chronic kidney diseases, and others is expected to drive the growth of Oman pharmaceutical industry market over the forecast period. For instance, according to the World Health Organization 2018 report, in 2018, coronary heart disease deaths in Oman reached 2,904 or 28.23% of total deaths. The age adjusted death rate is 179.48 per 100,000 population, which ranks Oman at 45th position in the world in coronary heart disease patient population. Moreover, according to the World Health Organization (WHO), chronic kidney disease (CKD) is the sixth main cause of death in Oman, with a rate of 18.10 per 100,000 population (2.97% of total deaths) every year caused due to CKD in Oman. Similarly, Oman was ranked 51st among the top world countries in which CKD is a major cause of death.

Key features of the study:

  • This report provides in-depth analysis of the India & Oman pharmaceutical industry market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2021–2030), considering 2020 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the India & Oman pharmaceutical industry market based on the following parameters – company highlights, types portfolio, key highlights, financial performance, and market strategies
  • Key companies covered as a part of this study include Pfizer, Inc., Bristol Myers Squibb, Sanofi S.A., F. Hoffmann-La Roche AG, Bayer AG, Novartis International AG, Merck & Co., Inc., AbbVie, GlaxoSmithKline plc, Eli Lilly and Company, Zydus Cadila, Aurobindo Pharma Ltd., Cipla Ltd., Dr. Reddy's Laboratories Ltd., Lupin Ltd., Sun Pharmaceutical Industries Limited, Serum Institute of India Pvt. Ltd., Biocon Limited, Strides Pharma Science Limited, and Unichem Laboratories
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The India & Oman pharmaceutical industry market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the India & Oman pharmaceutical industry market

Detailed Segmentation:

  • India & Oman Pharmaceutical Industry Market, By Drug:
    • Generic
    • Patented (Branded)
  • India & Oman Pharmaceutical Industry Market, By Type:
    • Prescription Drugs
    • Over the Counter Drugs
  • India & Oman Pharmaceutical Industry Market, By Drug Class:
    • Analgesics
    • Anesthetics
    • Antibacterials
    • Antidepressants
    • Corticosteroids
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
    • Anticonvulsants
    • Antivirals
    • Anticoagulants
    • ACE inhibitors
    • Hormonal agents
    • Insulin
    • Contraceptives
    • Diuretics
    • Vaccines
    • Others
  • India & Oman Pharmaceutical Industry Market, By Application:
    • Cardiovascular
      • Ischemic Heart Disease
      • Others
    • Hypertension
    • Musculoskeletal
    • Oncology
    • Anti-infective
    • Cirrhosis
    • Metabolic Disorder
      • Diabetes
      • Others
    • Weight Management
    • Central Nervous System
    • Genito-urinary
    • Kidney Disease
    • Gastrointestinal
    • Respiratory
    • Hematology
    • Dermatology
    • Ophthalmology
    • Others (Nutraceutical, Dentals, and Gynecology)
  • India & Oman Pharmaceutical Industry Market, By Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • India & Oman Pharmaceutical Industry Market, By Country:
    • India
    • Oman
  • Company Profiles
    • Pfizer, Inc.
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • SWOT Analysis
      • Strategies
    • Bristol Myers Squibb
    • Sanofi S.A.
    • Hoffmann-La Roche AG
    • Bayer AG
    • Novartis International AG
    • Merck & Co., Inc.
    • AbbVie Inc.
    • GlaxoSmithKline plc.
    • Eli Lilly and Company
    • Zydus Cadila
    • Aurobindo Pharma Ltd.
    • Cipla Ltd.
    • Reddy's Laboratories Ltd.
    • Lupin Ltd.
    • Sun Pharmaceutical Industries Limited
    • Serum Institute of India Pvt. Ltd.
    • Biocon Limited
    • Strides Pharma Science Limited
    • Unichem Laboratories

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Drug
      • Market Snapshot, By Type
      • Market Snapshot, By Drug Class
      • Market Snapshot, By Application
      • Market Snapshot, By Distribution Channel
      • Market Snapshot, By Country
      • Market Opportunity Map
  3. India & Oman Pharmaceutical Industry Market
    • Analysis of the Indian Pharmaceutical Industry
      • Drivers & Restraints
      • Market Opportunity
      • Market Trends
      • Impact Analysis
      • Mergers and Acquisitions
      • Epidemiology
      • PEST Analysis
      • SWOT Analysis
      • Regulatory Scenario
      • Reimbursement Scenario
      • Major Indian Exporters/Manufacturers (Global)
      • Major Indian Importers
      • Major Indian Exporters/Manufacturers (To Oman)
      • Indian Pharmaceutical Drugs Import Market
      • Indian Pharmaceutical Drugs Export Market
        • Indian Pharmaceutical Drugs Export to Oman Market
    • Analysis of the Oman Pharmaceutical Industry
      • Drivers & Restraints
      • Market Opportunity
      • Market Trends
      • Impact Analysis
      • Mergers and Acquisitions
      • Epidemiology
      • PEST Analysis
      • SWOT Analysis
      • Regulatory Scenario
      • Industry Regulations
        • Trade Regulations and Procedures For Export to Oman
        • Trade Barriers (Tariff, Non-tariff, etc.) and Other Entry-level Barriers for Indian Pharma Products in Oman
      • Reimbursement Scenario
      • Major Oman Exporters/Manufacturers (Global)
      • Major Oman Importers
      • Strategy For Indian Pharma Products In Oman
      • India's Strategy For Effectively Entering Oman Pharma Market
      • USP Of Indian Companies In The Oman Pharmaceutical Market And Positioning Strategy
      • Oman Pharmaceutical Drugs Import Market
      • Oman Pharmaceutical Drugs Export Market
        • Oman Pharmaceutical Drugs Export to India Market
      • Ayurvedic Drugs Market
        • Overview of Indian Ayurvedic Drugs
        • Ayurvedic Products by Indian Companies With Certification of Pharmaceutical Product (COPP) Granted As Per WHO-GMP Certification Scheme (1/2)
        • Overview of Oman Ayurvedic Drugs Import
        • Indian Ayurvedic Companies Registered in Oman
      • Strategies Adopted By Local Oman Manufacturers
  4. India & Oman Pharmaceutical Industry Market - Impact of Coronavirus (Covid-19) Pandemic
    • Economic Impact
    • Impact of COVID-19 on Pharmaceutical Market
    • Demand and Supply Chain Analysis
    • Government Initiative
  5. India & Oman Pharmaceutical Industry Market, By Drug, 2011 – 2030 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2030 (%)
      • Y-o-Y Growth Analysis, 2012 – 2030
      • Segment Trends
    • Generic
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Patented (Branded)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
  6. India & Oman Pharmaceutical Industry Market, By Type, 2011 – 2030 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2030 (%)
      • Y-o-Y Growth Analysis, 2012 – 2030
      • Segment Trends
    • Prescription Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Over the Counter Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million
  7. India & Oman Pharmaceutical Industry Market, By Drug Class, 2011 – 2030 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2030 (%)
      • Y-o-Y Growth Analysis, 2012 – 2030
      • Segment Trends
    • Analgesics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Anesthetics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Antibacterials
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Antidepressants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Corticosteroids
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Anticonvulsants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Antivirals
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Anticoagulants
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • ACE inhibitors
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Hormonal agents
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Insulin
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Contraceptives
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Diuretics
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Vaccines
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Others
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
  8. India & Oman Pharmaceutical Industry Market, By Application, 2011 – 2030 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2030 (%)
      • Y-o-Y Growth Analysis, 2012 – 2030
      • Segment Trends
    • Cardiovascular
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
      • Ischemic Heart Disease
      • Others
    • Hypertension
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Musculoskeletal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Oncology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Anti-infective
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Metabolic Disorder
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
      • Diabetes
      • Others
    • Weight Management
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Central Nervous System
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Genito-urinary
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Kidney Disease
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Gastrointestinal
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Respiratory
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Hematology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Dermatology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Ophthalmology
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Others (Nutraceutical, Dentals, and Gynecology)
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
  9. India & Oman Pharmaceutical Industry Market, By Distribution Channel, 2011 – 2030 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2030 (%)
      • Y-o-Y Growth Analysis, 2012 – 2030
      • Segment Trends
    • Hospital Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2011 – 2030 (US$ Million)
  10. India & Oman Pharmaceutical Industry Market, By Country, 2011 – 2030 (US$ Million)
    • Introduction
      • Market Share Analysis, 2021 and 2030 (%)
      • Y-o-Y Growth Analysis, 2012 – 2030
      • Regional Trends
    • India
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2011 – 2030 (US$ Million)
    • Oman
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Drug, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Type, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2011 – 2030 (US$ Million)
      • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2011 – 2030 (US$ Million)
  11. Case Study of Successful Foreign Pharma Product Entries Into    Oman Market
    • Case Study of 5 Successful Foreign Pharma Companies Entry Into Oman Market
    • Company Profiles (Global)
      • Pfizer, Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Bristol-Myers Squibb Company
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Sanofi S.A.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • F. Hoffmann-La Roche AG
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Bayer AG
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Novartis International AG
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Merck & Co., Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • AbbVie Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • GlaxoSmithKline plc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Eli Lilly and Company
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
    • Company Profiles (India)
      • Zydus Cadila
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Aurobindo Pharma Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Cipla Inc.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Dr. Reddy's Laboratories Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Lupin Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Sun Pharmaceutical Industries Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Serum Institute of India Pvt. Ltd.
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Biocon Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Strides Pharma Science Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
      • Unichem Laboratories Limited
        • Company Highlights
        • Products Portfolio
        • Key Highlights
        • Financial Performance
        • SWOT Analysis
        • Strategies
  12. Section
    • Research Methodology
    • About us

*Browse 89 market data tables and 64 figures on "India & Oman Pharmaceutical Industry Market” – India & Oman forecast to 2030

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo